Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Roivant Sciences is a US-based biotechnology company revolutionizing drug development. It establishes specialized subsidiaries (Vants) that leverage advanced technologies like AI and data science. The aim is to more efficiently discover and develop new therapies, accelerating patient access to healthcare solutions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Roivant Sciences is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Roivant Sciences last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.33 USD.
Across its last 4 earnings reports, Roivant Sciences stock moved by ±10.2% on average the following day. The largest reaction was +22.1% on 02/06/2026; 3 of 4 reactions were positive.
Roivant Sciences has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.